Practo and Lybrate don’t mess with cancer. But Onco’s panel of specialists is raring to take it on, never mind where the patient is. – ET Prime https://t.co/NG7ZQ5EGjQ
— The Propell Group (@ThePropellGroup) January 22, 2019
Practo and Lybrate don’t mess with cancer. But Onco’s panel of specialists is raring to take it on, never mind where the patient is. – ET Prime https://t.co/NG7ZQ5EGjQ
— The Propell Group (@ThePropellGroup) January 22, 2019